ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2037

Proteostasis Dysregulation and Autoinflammation in Patients with TRNT1 Deficiency

Angeliki Giannelou1, Qing Zhou2, Hongying Wang3, Abu-Asab Mones4, Hong-Wei Sun5, Deborah L. Stone6, Amanda K. Ombrello7, Wanxia L. Tsai8, Stephen Brooks9, Jehad H. Edwan5, Kimberly Risma10, Lucie Sramkova11, Abdullah Al Sonbul12, Sarita Joshi13, Helen C. Su14, Karyl Barron14, Massimo G. Gadina15, Gustavo Gutierrez-Cruz5, Markus Hafner5, Ivona Aksentijevich16 and Daniel L. Kastner16, 1National Human Genome Research Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2National Human Genome Research Institute, National Institutes of Health, Inflammatory Disease Branch, Bethesda, MD, 3National Human Genome Research Institute, Bethesda, MD, 4National Eye Institute, National Institutes of Health, Bethesda, MD, 5National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 6Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 7Inflammatory Disease Section, NHGRI, National Institutes of Health, Bethesda, MD, 8National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, 9NIAMS/NIH, Bethesda, MD, 10Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 11Charles University 2nd Faculty of Medicine and UH Motol, Prague, Czech Republic, 12King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia, 13Nationwide Children's Hospital, Columbus, OH, 14National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 15Translational Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 16National Human Genome Research Institute, National Institutes of Health, Inflammatory Disease Section, Bethesda, MD

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Autoinflammation, Gene Expression and therapeutic targeting

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Genetics, Genomics and Proteomics I

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Hypomorphic mutations in the TRNT1gene result in a syndrome of sideroblastic anemia, immunodeficiency, periodic fevers and developmental delay (SIFD). The TRNT1 enzyme is essential for tRNA maturation and regulation, aminoacylation and protein synthesis. Complete deficiency is incompatible with life.

Methods: Genetic studies included whole exome sequencing and candidate gene screening. Patient cells were used for deep RNA and tRNA sequencing, cytokine profiling, immunophenotyping, immunoblotting and electron microscopy (EM).

Results: We have identified 9 patients with biallelic missense mutations in TRNT1. 5 out of 9 mutations have not been reported. Patients suffered from recurrent fevers, variable degrees of immunodeficiency and a combination of inflammatory and degenerative disease. Inflammatory cytokines, mainly IL-6, IFN-g and IFN-induced cytokines were found elevated in the serum and in stimulated cells ex vivo. Deep tRNA sequencing of patients’ fibroblasts showed that more than two third of patient’s mature tRNAs were decreased compared to controls. EM microscopy of bone marrow and skin biopsy tissues showed striking abnormalities across all cell types, including pyknotic nuclei, disorganized cytoskeleton, extranuclear DNA, and abnormal mitochondria. We observed a mix of necroptotic and normal appearing cells in all tissues. Autophagosomal vesicles were observed intracellularly and in the serum. Intriguingly, the patient with the most severe inflammatory phenotype had evidence by EM of different, coexisting, types of cell death, proteinaceous substance and cellular debris in the bone marrow stroma. In agreement, gene expression profiling from patients’ fibroblasts and whole blood, showed that the top differentially expressed genes belonged to pathways involving DNA damage control, protein trafficking, acute phase response, and extracellular tissue homeostasis. By immunoprecipitation, we further determined that patients’ fibroblasts have malfunction in the maintenance of proteostasis as evidenced by dysregulation in proteasome and autophagy function, and accumulation of ubiquitinated proteins. No effective treatment has been described for this syndrome so far. Preliminary experience in our cohort suggests that treatment with a TNF-a inhibitor is beneficial for suppressing inflammation, stabilizing anemia and improving growth.

Conclusion: Mutations of TRNT1 enzyme lead to a severe and often fatal syndrome, linking protein homeostasis and autoinflammation. Future study of this disease will likely give new insights at cellular level about the role of protein homeostasis in immune cell development and susceptibility to inflammation in general. It might also provide more insights for targeted therapies of inflammatory diseases linked to protein degradation.


Disclosure: A. Giannelou, None; Q. Zhou, None; H. Wang, None; A. A. Mones, None; H. W. Sun, None; D. L. Stone, None; A. K. Ombrello, None; W. L. Tsai, None; S. Brooks, None; J. H. Edwan, None; K. Risma, None; L. Sramkova, None; A. Al Sonbul, None; S. Joshi, None; H. C. Su, None; K. Barron, None; M. G. Gadina, None; G. Gutierrez-Cruz, None; M. Hafner, None; I. Aksentijevich, None; D. L. Kastner, None.

To cite this abstract in AMA style:

Giannelou A, Zhou Q, Wang H, Mones AA, Sun HW, Stone DL, Ombrello AK, Tsai WL, Brooks S, Edwan JH, Risma K, Sramkova L, Al Sonbul A, Joshi S, Su HC, Barron K, Gadina MG, Gutierrez-Cruz G, Hafner M, Aksentijevich I, Kastner DL. Proteostasis Dysregulation and Autoinflammation in Patients with TRNT1 Deficiency [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/proteostasis-dysregulation-and-autoinflammation-in-patients-with-trnt1-deficiency/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/proteostasis-dysregulation-and-autoinflammation-in-patients-with-trnt1-deficiency/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology